Vikas Lifecare Ltd Falls to 52-Week Low of Rs.1.69 Amidst Weak Financial Metrics

2 hours ago
share
Share Via
Vikas Lifecare Ltd’s shares declined to a fresh 52-week low of Rs.1.69 today, marking a significant drop amid persistent underperformance relative to the broader market and its sector peers. The stock’s fall comes despite a marginal outperformance against the Trading & Distributors sector on the day, reflecting ongoing concerns about the company’s financial health and market position.
Vikas Lifecare Ltd Falls to 52-Week Low of Rs.1.69 Amidst Weak Financial Metrics



Stock Price Movement and Market Context


On 20 Jan 2026, Vikas Lifecare Ltd recorded its lowest price in the past year at Rs.1.69, down by 0.57% on the day. This new low contrasts sharply with its 52-week high of Rs.4.05, representing a decline of nearly 58%. The stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained downward momentum.


In comparison, the Sensex opened flat but subsequently declined by 300.46 points, or 0.41%, closing at 82,906.92. The index remains 3.92% below its 52-week high of 86,159.02 and has experienced a three-week consecutive fall, losing 3.33% over this period. Despite the broader market weakness, Vikas Lifecare marginally outperformed its sector by 0.61% today, though this did little to offset its longer-term decline.



Financial Performance and Fundamental Metrics


Vikas Lifecare’s financial indicators continue to reflect challenges. The company has not declared results in the last six months, contributing to uncertainty around its current financial standing. Its long-term fundamental strength is rated weak, with a MarketsMOJO Mojo Score of 3.0 and a Mojo Grade of Strong Sell, upgraded from Sell on 22 Jul 2024. The Market Cap Grade stands at 4, indicating a relatively small market capitalisation.


The company’s ability to service debt remains constrained, with an average EBIT to Interest ratio of -0.77, signalling that earnings before interest and tax are insufficient to cover interest expenses. This is compounded by a low average Return on Equity of 1.43%, indicating limited profitability generated from shareholders’ funds.




Fundamentals that don't lie! This Small Cap from Trading shows consistent growth and price strength over time. A reliable pick you can truly count on.



  • - Strong fundamental track record

  • - Consistent growth trajectory

  • - Reliable price strength


Count on This Pick →




Recent Quarterly Results and Profitability Trends


The company’s latest quarterly results, reported in June 2025, showed a decline in net sales to Rs.92.38 crores, down 23.0% compared to the previous four-quarter average. Profit after tax (PAT) also fell sharply by 56.2% to a loss of Rs.3.96 crores. Interest expenses for the nine months ended grew by 36.03% to Rs.4.04 crores, further pressuring profitability.


Over the past year, Vikas Lifecare’s profits have deteriorated by 302.2%, reflecting a significant erosion in earnings. The stock’s return over the same period was negative 56.36%, markedly underperforming the Sensex, which gained 7.54% in the last year. This underperformance extends over longer periods as well, with the stock lagging the BSE500 index over the last three years, one year, and three months.



Valuation and Risk Assessment


The stock is considered risky relative to its historical valuations. Its current trading levels are below all major moving averages, indicating a bearish trend. The majority of shareholders are non-institutional, which may affect liquidity and market confidence. The combination of weak profitability, rising interest costs, and lack of recent financial disclosures contributes to the cautious market stance on the stock.




Vikas Lifecare Ltd or something better? Our SwitchER feature analyzes this micro-cap Trading & Distributors stock and recommends superior alternatives based on fundamentals, momentum, and value!



  • - SwitchER analysis complete

  • - Superior alternatives found

  • - Multi-parameter evaluation


See Smarter Alternatives →




Sector and Market Comparison


Within the Trading & Distributors sector, Vikas Lifecare’s performance contrasts with the broader market trends. While the sector has seen fluctuations, the company’s stock has consistently traded below its moving averages, signalling persistent weakness. The Sensex’s recent three-week decline of 3.33% and its position below the 50-day moving average reflect a cautious market environment, yet Vikas Lifecare’s sharper decline highlights company-specific pressures.


The stock’s 52-week low of Rs.1.69 is a notable milestone, underscoring the challenges faced by the company in maintaining investor confidence and market valuation. The gap between the current price and the 52-week high of Rs.4.05 emphasises the extent of the downtrend over the past year.



Shareholding Pattern and Market Capitalisation


Non-institutional investors hold the majority stake in Vikas Lifecare, which may influence trading volumes and price stability. The company’s market capitalisation grade of 4 indicates a relatively small market cap, which can contribute to higher volatility and sensitivity to market movements.


Overall, the stock’s trajectory over the past year and recent months reflects a combination of subdued financial performance, increased interest costs, and limited recent disclosures, all contributing to its current valuation and trading levels.



Summary of Key Metrics


To summarise, Vikas Lifecare Ltd’s key financial and market metrics as of 20 Jan 2026 are:



  • New 52-week low price: Rs.1.69

  • 52-week high price: Rs.4.05

  • One-year stock return: -56.36%

  • Sensex one-year return: +7.54%

  • EBIT to Interest ratio (avg): -0.77

  • Return on Equity (avg): 1.43%

  • Net sales decline in latest quarter: -23.0%

  • PAT decline in latest quarter: -56.2%

  • Interest expense growth (9 months): +36.03%

  • Mojo Score: 3.0 (Strong Sell)

  • Market Cap Grade: 4



The combination of these factors has culminated in the stock’s current position at a 52-week low, reflecting the market’s assessment of the company’s recent performance and outlook.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News